Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody
The COVID-19 pandemic has reemphasized the need to identify safe
IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus
Staphylococcus aureus causes a wide range of diseases from skin infections
Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques
Staphylococcus aureus is a leading cause of significant morbidity and mortality
Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization
The severe death toll caused by the recent outbreak of
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses
Here, we describe monoclonal antibodies with cross-reactivity to several filoviruses,
Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein
Keck et al., J Virol, 2014
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
Fusco et al., PLoS Pathog, 2015
Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles
Warfield et al., PLoS One, 2015
